These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial. Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ Trials; 2021 May; 22(1):342. PubMed ID: 34001174 [TBL] [Abstract][Full Text] [Related]
4. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T; Trials; 2021 May; 22(1):343. PubMed ID: 34001215 [TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related]
8. Association between patient-reported onset-to-door time and mortality in patients hospitalized with COVID-19 disease. Yadav KN; Hemmons J; Snider CK; Patel A; Childs M; Delgado MK Am J Emerg Med; 2024 Mar; 77():169-176. PubMed ID: 38157591 [TBL] [Abstract][Full Text] [Related]
9. Association of Social and Behavioral Risk Factors With Mortality Among US Veterans With COVID-19. Kelly JD; Bravata DM; Bent S; Wray CM; Leonard SJ; Boscardin WJ; Myers LJ; Keyhani S JAMA Netw Open; 2021 Jun; 4(6):e2113031. PubMed ID: 34106264 [TBL] [Abstract][Full Text] [Related]
10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Substance Use Among Adult Emergency Department Patients: Prevalence, Severity, and Need for Intervention. Beaudoin FL; Baird J; Liu T; Merchant RC Acad Emerg Med; 2015 Nov; 22(11):1307-15. PubMed ID: 26473942 [TBL] [Abstract][Full Text] [Related]
12. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19. Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015395. PubMed ID: 38032024 [TBL] [Abstract][Full Text] [Related]
13. Convalescent plasma for people with COVID-19: a living systematic review. Iannizzi C; Chai KL; Piechotta V; Valk SJ; Kimber C; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Jindal A; Cryns N; Estcourt LJ; Kreuzberger N; Skoetz N Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013600. PubMed ID: 36734509 [TBL] [Abstract][Full Text] [Related]
14. Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System. Gu T; Mack JA; Salvatore M; Prabhu Sankar S; Valley TS; Singh K; Nallamothu BK; Kheterpal S; Lisabeth L; Fritsche LG; Mukherjee B JAMA Netw Open; 2020 Oct; 3(10):e2025197. PubMed ID: 33084902 [TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
16. Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in New York City. Ogedegbe G; Ravenell J; Adhikari S; Butler M; Cook T; Francois F; Iturrate E; Jean-Louis G; Jones SA; Onakomaiya D; Petrilli CM; Pulgarin C; Regan S; Reynolds H; Seixas A; Volpicelli FM; Horwitz LI JAMA Netw Open; 2020 Dec; 3(12):e2026881. PubMed ID: 33275153 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America. Yang JY; Parkins MD; Canakis A; Aroniadis OC; Yadav D; Dixon RE; Elmunzer BJ; Forbes N; JAMA Netw Open; 2021 Jan; 4(1):e2035699. PubMed ID: 33507259 [TBL] [Abstract][Full Text] [Related]
19. Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial. Gharbharan A; Jordans C; Zwaginga L; Papageorgiou G; van Geloven N; van Wijngaarden P; den Hollander J; Karim F; van Leeuwen-Segarceanu E; Soetekouw R; Lammers J; Postma D; Kampschreur L; Groeneveld G; Swaneveld F; van der Schoot CE; Götz H; Haagmans B; Koopmans M; Bogers S; Geurtsvankessel C; Zwaginga JJ; Rokx C; Rijnders B; Clin Microbiol Infect; 2023 Feb; 29(2):208-214. PubMed ID: 36007870 [TBL] [Abstract][Full Text] [Related]
20. A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada. Kendall CE; Boucher LM; Mark AE; Martin A; Marshall Z; Boyd R; Oickle P; Diliso N; Pineau D; Renaud B; Rose T; LeBlanc S; Tyndall M; Lee OM; Bayoumi AM Harm Reduct J; 2017 May; 14(1):16. PubMed ID: 28494791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]